Guardant Health Raises $284.4M in Upsized Public Offering, Plans to Repurchase 2027 Notes

Guardant Health has priced an upsized public offering of 3.33 million shares of common stock at $90 per share, raising approximately $284.4 million. The company intends to use the proceeds for general corporate purposes, including repurchasing a portion of its 0% convertible senior notes due 2027. The offering is expected to close on November 7, 2025, and Goldman Sachs, Jefferies, Leerink Partners, and Guggenheim Securities are acting as joint book-running managers.